-
-
-
-
-
-
-
Supernus Pharmaceuticals (SUPN) PT Raised to $65 at TD Cowen
-
-
-
-
-
-
-
Supernus Pharmaceuticals (SUPN) PT Raised to $50 at Stifel
-
-
-
-
-
-
-
Supernus Pharmaceuticals (SUPN) PT Raised to $63 at Cantor Fitzgerald
-
-
-
-
-
-
-
Piper Sandler on Supernus Pharmaceuticals (SUPN): Sage Purchase A Head-Scratcher
-
-
-
-
-
-
-
Supernus Pharma (SUPN) Announces Topline Results from Phase 2b Study in Adults with Treatment Resistant Depression
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on Supernus Pharmaceuticals (SUPN)
-
-
-
-
444,290 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

